PocketHealth | Revolutionizing Healthcare Access and Efficiency29 Mar 2024
PocketHealth, fueled by a $33 million Series B funding, redefines healthcare accessibility and efficiency. Founded in 2016, it empowers patients... Continue Reading
|
Hippocratic AI | Revolutionizing Healthcare with Generative AI29 Mar 2024
Hippocratic AI secures $53 million in oversubscribed Series A funding, bringing total raised to $120 million, with a valuation of... Continue Reading
|
Conduce Health | Pioneering Value-Based Care Revolution29 Mar 2024
Conduce Health secures $3M funding for its innovative approach to value-based care, addressing challenges in specialty care coordination. Their marketplace... Continue Reading
|
Cybin | Revolutionizing Mental Health with Innovative Psychedelic Therapies29 Mar 2024
Cybin Inc. (NYSE American: CYBN) secures $150M in private funding, led by Deep Track Capital, to advance CYB003, a groundbreaking... Continue Reading
|
AI Revolutionizes Surgery | J&J and NVIDIA Partner26 Mar 2024
Johnson & Johnson MedTech and NVIDIA collaborate to integrate AI into surgical procedures, aiming to enhance real-time analysis and decision-making... Continue Reading
|
AI-Powered Healthcare | Banner Health’s Transformational Partnership26 Mar 2024
Banner Health in Phoenix deepens its collaboration with Regard, a Los Angeles-based clinical decision software firm, to integrate AI-driven solutions... Continue Reading
|
Revolutionizing Rheumatology | Remission & Sentara’s Dynamic Partnership26 Mar 2024
Remission Medical and Sentara Health join forces to enhance rheumatology care access. Leveraging telehealth solutions, patients can receive virtual triage... Continue Reading
|
Advancing Healthcare| Innovations in Screening and Monitoring26 Mar 2024
The Global Fund collaborates with VinBrain to enhance TB screening in Vietnam. VinBrain’s AI technology aims to expedite diagnosis and... Continue Reading
|
PureTech Celebrates Karuna Acquisition by Bristol Myers Squibb26 Mar 2024
PureTech Health plc announces the acquisition of Karuna Therapeutics, Inc. by Bristol Myers Squibb for $14 billion, emphasizing KarXT’s potential... Continue Reading
|
BiomX Acquires APT | Advancing Phage Therapy Innovations26 Mar 2024
BiomX Inc. (NYSE American: PHGE) has finalized its acquisition of Adaptive Phage Therapeutics, Inc. (APT), bolstering its position in phage... Continue Reading
|